REG - Induction Healthcare - Four London NHS Trusts sign with Induction Zesty

Induction HealthcareAnnouncement

04/04/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220404:nRSD0241Ha&default-theme=true

RNS Number : 0241H  Induction Healthcare Group PLC   04 April 2022

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Four London NHS Trusts sign with Induction Zesty

 

NHS Trusts in South West London partner with Induction to support long-term
outpatient care transformation

 

Induction (AIM: INHC), a leading virtual care platform driving digital
transformation of healthcare systems worldwide, announces that the South West
London Integrated Care System ('ICS') will deploy Induction Zesty to support
their outpatient transformation programme. The partnership comes at a time of
significant national focus and spending on digital transformation for NHS
secondary care providers in England, and Induction Zesty can play its part
supporting Trusts across South West London ('SWL').

 

Induction Zesty is a digital front door for hospitals, with an intuitive
interface that empowers patients to take control of their appointments,
correspondence and virtual consultations from the convenience of their
smartphone. For the first time, patients can see a joined up view of their
care journey, spanning multiple care providers, via a single digital platform.

 

Comprising four of the acute NHS Trusts within SWL, the combined contracts have terms ranging between 2 and 9 years and will result in total revenue of c. £3,600,000 with an ARR of around £650,000 from FY23 onwards. We expect to recognise around £450K of revenue in FY23 in respect of these contracts as implementation work is completed and the sites go live. The contracts were in part driven by a strategic collaboration with Cerner Corporation ("Cerner") (NASDAQ: CERN) and Induction, who created a joint product, made available as part of a value-added reseller agreement to NHS Trusts that are already Cerner clients as an extension to their existing Cerner EPR contracts.

 

In June 2021, Induction acquired Attend Anywhere which is South West London's preferred platform for remote video consultations. The opportunity to combine both platforms' complementary capabilities will strengthen patient engagement and underpins the Company's growth strategy for FY23 and beyond.

 

Induction CEO, James Balmain, said: "This is an exciting first step and strong
proof point in our strategy to support regional digital transformation via
newly forming Integrated Care Systems. We have a strong pipeline of further
Cerner customers who are keen to purchase the joint Induction / Cerner patient
portal. Equally encouraging is the positive reaction we've seen from customers
around the integration of Attend Anywhere into our Induction Zesty product."

 

-ENDS-

 

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

                                                      (mailto:induction@walbrookpr.com)
 James Balmain, Chief Executive Officer
 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        +44 (0)20 7933 8780
 Paul McManus / Alice Woodings

 

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transform care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUPUAWCUPPGCG